Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )

Biological insight in new drug combinations

Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Biological insight in new drug combinations ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )

Managing osteonecrosis of the jaw

Dr Robert Marx - University of Miami Hospital, Miami, USA

Managing osteonecrosis of the jaw ( Dr Robert Marx - University of Miami Hospital, Miami, USA )

Celebrating a 10 year partnership: ecancer and the IEO

Prof Gordon McVie - Editor in Chief, ecancer

Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )

Precision medicine enabled histology agnostic development of immunotherapeutics

Dr Roy Baynes - Merck Research Laboratories, Rahway, USA

Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )

Triplet therapy for all comers in the CLL-BAG trial

Dr Paula Cramer – University of Cologne, Cologne, Germany

Triplet therapy for all comers in the CLL-BAG trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )

Blood thinners a risk with cancer-associated venous thromboembolism

Dr Alejandro Lazo-Langner - Department of Medicine, Western University, London...

Blood thinners a risk with cancer-associated venous thromboembolism ( Dr Alejandro Lazo-Langner - Department of Medicine, Western University, London, Ontario, Canada )

Risk and benefit of anti-coagulants for elderly patients with cancer-associated...

Dr Alejandro Lazo-Langner - Department of Medicine, Western University, London...

Risk and benefit of anti-coagulants for elderly patients with cancer-associated venous thromboembolism ( Dr Alejandro Lazo-Langner - Department of Medicine, Western University, London, Ontario, Canada )

Delayed exposure to common infections causes acute childhood leukaemia

Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical...

Delayed exposure to common infections causes acute childhood leukaemia ( Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical Immunology, Düsseldorf, Germany )

Dacomitinib for EGFR positive lung cancer

Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China

Dacomitinib for EGFR positive lung cancer ( Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China )

Dose escalation results of ceritinib and nivolumab for ALK NSCLC

Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain

Dose escalation results of ceritinib and nivolumab for ALK NSCLC ( Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain )

Tivantinib as second line therapy for high-MET HCC

Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy

Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )

More from ecancer